Morbidity and mortality in paid Austrian plasma donors infected with hepatitis C at plasma donation in the 1970s

被引:33
作者
Ferenci, Peter
Ferenci, Stefan
Datz, Christian
Rezman, Ingo
Oberaigner, Wilhelm
Strauss, Reinhild
机构
[1] Med Univ Vienna, Dept Internal Med 4, Vienna, Austria
[2] Fed Minist Hlth & Women, Hepatitis C Fdn, Vienna, Austria
[3] Hosp Oberndorf, Dept Internal Med, Salzburg, Austria
[4] Tyrolean State Hosp Ltd, Dept Clin Epidemiol, Innsbruck, Austria
关键词
hepatitis C virus; chronic hepatitis C; natural history; plasmapheresis; blood donation; advanced liver disease; antiviral treatment; morbidity; mortality;
D O I
10.1016/j.jhep.2007.01.023
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Between 1964 and 1987 several epidemic outbreaks of hepatitis C virus infection linked to plasma donation occurred at plasmapheresis centres in Austria. Data collected by a Foundation to help the victims enabled us to study the natural history of chronic hepatitis C inthis cohort. Methods: Medical records and charts of donors accepted by the Foundation were analyzed. Results: Four hundred and eighty-five subjects (439 males; mean age at infection: 22 years) were included. Mean follow-up was 31 years. Thirty-four percent of plasma donors had advanced liver disease; alcohol abuse and diabetes were related to progression. Twenty-one patients developed hepatocellular carcinoma; 36 underwent liver transplantation. Six donors cleared the virus spontaneously. Forty died, with death directly related to liver disease in 25 donors. Overall and transplant-free 35-year cumulative survival rates were 84% and 74%, respectively. Three hundred and nineteen patients received and 291 completed antiviral treatment. All 56 who achieved a sustained virologic response are alive and well; 14 non-responders died and nine underwent liver transplantation. Conclusions: Thirty-one years after virus infection, advanced liver disease has developed in a third of patients, with an overall mortality of 7%. These data underline the progressive nature of chronic hepatitis C infection and the need to identify and treat infected subjects. (c) 2007 Published by Elsevier B.V. on behalf of the European Association for the Study of the Liver.
引用
收藏
页码:31 / 36
页数:6
相关论文
共 28 条
[1]   HCV natural history: The retrospective and prospective in perspective [J].
Alter, HJ .
JOURNAL OF HEPATOLOGY, 2005, 43 (04) :550-552
[2]   THE NATURAL-HISTORY OF COMMUNITY-ACQUIRED HEPATITIS-C IN THE UNITED-STATES [J].
ALTER, MJ ;
MARGOLIS, HS ;
KRAWCZYNSKI, K ;
JUDSON, FN ;
MARES, A ;
ALEXANDER, WJ ;
HU, PY ;
MILLER, JK ;
GERBER, MA ;
SAMPLINER, RE ;
MEEKS, EL ;
BEACH, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (27) :1899-1905
[3]   High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C [J].
Bressler, BL ;
Guindi, M ;
Tomlinson, G ;
Heathcote, J .
HEPATOLOGY, 2003, 38 (03) :639-644
[4]   The natural course of hepatitis C virus infection 18 years after an epidemic outbreak of non-A, non-B hepatitis in a plasmapheresis centre [J].
Datz, C ;
Cramp, M ;
Haas, T ;
Dietze, O ;
Nitschko, H ;
Froesner, G ;
Muss, N ;
Sandhofer, F ;
Vogel, W .
GUT, 1999, 44 (04) :563-567
[5]  
EDERER F, 1962, CANCER, V15, P425, DOI 10.1002/1097-0142(196203/04)15:2<425::AID-CNCR2820150227>3.0.CO
[6]  
2-#
[7]   Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma [J].
El-Serag, HB ;
Tran, T ;
Everhart, JE .
GASTROENTEROLOGY, 2004, 126 (02) :460-468
[8]   Rising incidence of hepatocellular carcinoma in the United States [J].
El-Serag, HB ;
Mason, AC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (10) :745-750
[9]  
FERENCI P, 1979, VERH DTSCH GES INN M, V85, P553
[10]   CANCER SURVIVAL CORRECTED FOR HETEROGENEITY IN PATIENT WITHDRAWAL [J].
HAKULINEN, T .
BIOMETRICS, 1982, 38 (04) :933-942